feed,title,long_url,short_url
Benzinga,"Despite Neurocrine's Epilepsy Drug Missing Primary Goal In Pediatric Trial, Analyst Sees Strong Growth",https://benzinga.com/analyst-ratings/analyst-color/22/12/29987626/despite-neurocrines-epilepsy-drug-missing-primary-goal-in-pediatric-trial-analyst-s,https://da.gd/b7TFoE
